Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1059)
Liquidia Corp (LQDA)
Caligan Partners LP — Director
Shares
5,300
Price
$59.98
Total Value
$317.89K
Shares Held After
8,138,951
% of Holdings
0.1%
Liquidia Corp (LQDA)
Caligan Partners LP — Director
Shares
5,300
Price
$59.98
Total Value
$317.89K
Shares Held After
8,133,651
% of Holdings
0.1%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$58.65
Total Value
$1.47M
Shares Held After
1,148,095
% of Holdings
2.1%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
62,970
Price
$0.45
Total Value
$28.34K
Shares Held After
1,041,342
% of Holdings
5.7%
Ainos, Inc. (AIMD)
chiang yao-chung — Director
Shares
2,200
Price
$1.68
Total Value
$3.70K
Shares Held After
3,529
% of Holdings
62.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$572.36
Total Value
$68.68K
Shares Held After
40,513
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
562
Price
$571.24
Total Value
$321.04K
Shares Held After
40,633
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,099
Price
$570.35
Total Value
$626.82K
Shares Held After
41,195
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,393
Price
$569.42
Total Value
$793.20K
Shares Held After
42,294
% of Holdings
3.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,640
Price
$568.46
Total Value
$932.28K
Shares Held After
43,687
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,149
Price
$567.38
Total Value
$651.92K
Shares Held After
45,327
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,140
Price
$566.34
Total Value
$1.21M
Shares Held After
46,476
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,237
Price
$565.54
Total Value
$699.57K
Shares Held After
48,616
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
109
Price
$562.31
Total Value
$61.29K
Shares Held After
49,853
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
51
Price
$561.52
Total Value
$28.64K
Shares Held After
49,962
% of Holdings
0.1%
GYRE THERAPEUTICS, INC. (GYRE)
Ye Weiguo — Chief Operating Officer
Shares
9,120
Price
$6.37
Total Value
$58.09K
Shares Held After
700,000
% of Holdings
1.3%
Kura Oncology, Inc. (KURA)
Powl Brian T. — Chief Commercial Officer
Shares
339
Price
$9.21
Total Value
$3.12K
Shares Held After
183,614
% of Holdings
0.2%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
3,500
Price
$75.69
Total Value
$264.92K
Shares Held After
153,902
% of Holdings
2.2%
Kura Oncology, Inc. (KURA)
FORD KATHLEEN — Chief Operating Officer
Shares
2,257
Price
$9.08
Total Value
$20.48K
Shares Held After
153,560
% of Holdings
1.4%
Artiva Biotherapeutics, Inc. (ARTV)
Aslan Fred — Director
Shares
27,116
Price
$9.01
Total Value
$244.25K
Shares Held After
1,535,082
% of Holdings
1.7%
Artiva Biotherapeutics, Inc. (ARTV)
Bush Jennifer — COO, CLO, Compliance Officer
Shares
8,790
Price
$9.01
Total Value
$79.18K
Shares Held After
337,920
% of Holdings
2.5%
Artiva Biotherapeutics, Inc. (ARTV)
Banerjee Subhashis — Chief Medical Officer
Shares
7,037
Price
$9.01
Total Value
$63.39K
Shares Held After
144,963
% of Holdings
4.6%
Artiva Biotherapeutics, Inc. (ARTV)
Horan Christopher — Chief Tech Operations Officer
Shares
7,002
Price
$9.01
Total Value
$63.07K
Shares Held After
293,450
% of Holdings
2.3%
Artiva Biotherapeutics, Inc. (ARTV)
Raymon Heather — SVP, Research and Development
Shares
3,095
Price
$9.01
Total Value
$27.88K
Shares Held After
148,228
% of Holdings
2.0%
MeiraGTx Holdings plc (MGTX)
Forbes Alexandria — Director
Shares
62,000
Price
$9.17
Total Value
$568.54K
Shares Held After
1,387,695
% of Holdings
4.3%
INSMED Inc (INSM)
Lewis William — Director
Shares
7,975
Price
$106.97
Total Value
$853.09K
Shares Held After
273,037
% of Holdings
2.8%
INSMED Inc (INSM)
Lewis William — Director
Shares
11,836
Price
$106.39
Total Value
$1.26M
Shares Held After
281,012
% of Holdings
4.0%
INSMED Inc (INSM)
Lewis William — Director
Shares
5,753
Price
$105.32
Total Value
$605.91K
Shares Held After
292,848
% of Holdings
1.9%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
6,009
Price
$13.98
Total Value
$83.98K
Shares Held After
916,152
% of Holdings
0.7%
Shares
1,700,000
Price
$4.35
Total Value
$7.39M
Shares Held After
3,792,171
% of Holdings
31.0%
Adaptive Biotechnologies Corp (ADPT)
PISKEL KYLE — Chief Financial Officer
Shares
3,115
Price
$13.04
Total Value
$40.62K
Shares Held After
256,725
% of Holdings
1.2%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$56.77
Total Value
$1.42M
Shares Held After
1,173,095
% of Holdings
2.1%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
22,184
Price
$0.50
Total Value
$11.09K
Shares Held After
1,104,312
% of Holdings
2.0%
Atara Biotherapeutics, Inc. (ATRA)
Nguyen AnhCo — Director
Shares
5,241
Price
$9.13
Total Value
$47.84K
Shares Held After
137,837
% of Holdings
3.7%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
2,978
Price
$20.35
Total Value
$60.60K
Shares Held After
362,152
% of Holdings
0.8%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
12,022
Price
$19.96
Total Value
$239.98K
Shares Held After
365,130
% of Holdings
3.2%
Fortrea Holdings Inc. (FTRE)
Parks Robert — Chief Accounting Officer
Shares
2,000
Price
$13.44
Total Value
$26.88K
Shares Held After
20,389
% of Holdings
8.9%
Atara Biotherapeutics, Inc. (ATRA)
Grant-Huerta Yanina — Chief Accounting Officer
Shares
2,414
Price
$9.13
Total Value
$22.04K
Shares Held After
49,636
% of Holdings
4.6%
Pharvaris N.V. (PHVS)
Modig Berndt — Director
Shares
2,292
Price
$29.22
Total Value
$66.98K
Shares Held After
137,500
% of Holdings
1.6%
Ainos, Inc. (AIMD)
chiang yao-chung — Director
Shares
500
Price
$1.65
Total Value
$825.00
Shares Held After
1,329
% of Holdings
37.6%
Corvus Pharmaceuticals, Inc. (CRVS)
MILLER RICHARD A MD — Director
Shares
1,932
Price
$12.01
Total Value
$23.20K
Shares Held After
1,195,035
% of Holdings
0.2%
Corvus Pharmaceuticals, Inc. (CRVS)
MILLER RICHARD A MD — Director
Shares
5,000
Price
$12.05
Total Value
$60.25K
Shares Held After
1,193,103
% of Holdings
0.4%
Replimune Group, Inc. (REPL)
Hill Emily Luisa — Chief Financial Officer
Shares
7,812
Price
$5.08
Total Value
$39.68K
Shares Held After
236,556
% of Holdings
3.2%
Replimune Group, Inc. (REPL)
Sarchi Christopher — Chief Commercial Officer
Shares
8,626
Price
$5.08
Total Value
$43.82K
Shares Held After
192,962
% of Holdings
4.3%
Replimune Group, Inc. (REPL)
Schwendenman Andrew — Chief Accounting Officer
Shares
7,894
Price
$5.08
Total Value
$40.10K
Shares Held After
107,057
% of Holdings
6.9%
Lexeo Therapeutics, Inc. (LXEO)
Otero Jose Manuel — Chief Operating Officer
Shares
1,302
Price
$5.07
Total Value
$6.61K
Shares Held After
130,088
% of Holdings
1.0%
Replimune Group, Inc. (REPL)
Patel Sushil — Director
Shares
37,324
Price
$5.08
Total Value
$189.61K
Shares Held After
747,492
% of Holdings
4.8%
Replimune Group, Inc. (REPL)
Astley-Sparke Philip — Director
Shares
17,657
Price
$5.08
Total Value
$89.70K
Shares Held After
1,412,414
% of Holdings
1.2%
Replimune Group, Inc. (REPL)
Xynos Konstantinos — Chief Medical Officer
Shares
14,023
Price
$5.08
Total Value
$71.24K
Shares Held After
235,662
% of Holdings
5.6%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
223
Price
$41.21
Total Value
$9.19K
Shares Held After
25,000
% of Holdings
0.9%
Showing 651–700 of 1059 transactions (page 14 of 22)